Natalie Yeadon looks at how the industry can help healthcare professionals, patients, and their families combat false and misleading scientific information.
Amgen has chalked up a victory in a patent infringement lawsuit with Regeneron over blockbuster ophthalmic drug Eylea and decided to launch its biosimilar in the US – even though the legal